Faculty who have authored publication Ixekizumab sustains high level of efficacy and favourable safety profile over 4 years in patients with moderate psoriasis: results from UNCOVER-3 study.
Name | Title | Department | Institution |
---|---|---|---|
Kenneth Brian Gordon MD | Chair, Professor | Dermatology | Medical College of Wisconsin |